ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced the U.S. Food and Drug Administration (FDA) has approved the Company’s supplemental New Drug Application (sNDA) for BROMDAY(TM) (bromfenac ophthalmic solution) 0.09% as a once-daily prescriptio…
Category: News
Gene Therapy A Future Possibility In Glaucoma, Clinician Says
With 14 regions of the genome associated with primary open-angle glaucoma known and four genes identified, possible applications for genetics in glaucoma could include an additional therapeutic option, a clinician said here.
Push And Pull Get Eyes To Work Together
Researchers appear to have found a better way to correct sensory eye dominance, a condition in which an imbalance between the eyes compromises fine depth perception. The key is a push-pull training method in which the weak eye is made to work while vis…
Carl Zeiss Meditec Introduces New Innovations: ‘Creating What’s To Come’ At AAO 2010
AAO Booth #1408 – Carl Zeiss Meditec today unveiled its newest product innovations at the 2010 American Academy of Ophthalmology annual meeting in Chicago. Powered by the FORUM Ophthalmic Data Management System, the new Glaucoma Workplace features FORU…
ISTA Pharmaceuticals Receives FDA Approval For BROMDAY
ISTA Pharmaceuticals, Inc. , today announced the U.S. Food and Drug Administration (FDA) has approved the Company’s supplemental New Drug Application (sNDA) for BROMDAY (bromfenac ophthalmic solution) 0.09% as a once-daily prescription eye drop for the…
Carl Zeiss Meditec Introduces New Innovations: ‘Creating What’s To Come’ At AAO 2010
AAO Booth #1408 – Carl Zeiss Meditec today unveiled its newest product innovations at the 2010 American Academy of Ophthalmology annual meeting in Chicago. Powered by the FORUM Ophthalmic Data Management System, the new Glaucoma Workplace features FORU…
ISTA Pharmaceuticals Receives FDA Approval For BROMDAY
ISTA Pharmaceuticals, Inc. , today announced the U.S. Food and Drug Administration (FDA) has approved the Company’s supplemental New Drug Application (sNDA) for BROMDAY (bromfenac ophthalmic solution) 0.09% as a once-daily prescription eye drop for the…
Issuing First Report On NTDs, WHO Aims For ‘Complete Control’ By 2015
The WHO “said on Thursday that it was aiming for ‘complete control’ by 2015 of tropical diseases that affect one billion impoverished people” and kill an estimated 534,000 people each year, Agence France-Presse reports (10/14)…
Douglas A. Jabs, M.D., Honored With Jackson Memorial Lecture By The American Academy Of Ophthalmology
Douglas A. Jabs, MD, MBA, Professor and Chair of the Department of Ophthalmology, CEO of the Faculty Practice Associates, and Dean for Clinical Affairs at The Mount Sinai Medical Center, has been selected to deliver the prestigious Jackson Memorial Lec…
Eye Exercises Might Boost Fine Depth Perception
A new study says a push-pull training method is a good way to correct a condition called sensory eye dominance, in which an imbalance between the vision strength of the eyes impairs fine depth perception.
Beaver-Visitec International To Focus On Ophthalmic And Microsurgery Products And Services
Beaver-Visitec International (Beaver-Visitec), a new company formed from the purchase of the ophthalmic systems businesses from BD (Becton, Dickinson and Company) and Medtronic, announced today that it will focus solely on products and services for oph…
Beaver-Visitec International To Focus On Ophthalmic And Microsurgery Products And Services
Beaver-Visitec International (Beaver-Visitec), a new company formed from the purchase of the ophthalmic systems businesses from BD (Becton, Dickinson and Company) and Medtronic, announced today that it will focus solely on products and services for oph…
MMC Effective For Ocular Surface Neoplasia, With Short- and Long-Term Complications
Topical mitomycin C chemotherapy yielded qualified success in managing ocular surface neoplasia, a study found.
"Poppers" May Cause Serious Eye Damage: Study
Getting high by inhaling the vapors of alkyl nitrite capsules, commonly known as “poppers,” can seriously damage the light-sensing cells lining the retina of the eye, French doctors reported on Wednesday.
Sequenom Announces Formation Of Ophthalmology Clinical Advisory Board
Sequenom, Inc. (Nasdaq: SQNM) today announced the formation of a new clinical advisory board focusing on retinal diseases and conditions. The initial three distinguished thought-leaders will provide guidance to Sequenom and Sequenom Center for Molecula…
Beaver-Visitec International To Focus On Ophthalmic And Microsurgery Products And Services
Beaver-Visitec International (Beaver-Visitec), a new company formed from the purchase of the ophthalmic systems businesses from BD (Becton, Dickinson and Company) and Medtronic, announced today that it will focus solely on products and services for oph…
Monthly Anti-VEGF Dosing Associated With Lowest Risk Of Macular Hemorrhage
Patients with neovascular age-related macular degeneration being treated with monthly dosing of intravitreal anti-VEGF therapy have the lowest rate of macular hemorrhage compared with patients treated with sham or alternative therapy and have lower rat…
California: Many Americans In The Dark When Protecting Their Eyes From The Sun
When it comes to working and playing in the great outdoors, many Americans know they should keep their skin protected from the sun; however, a new survey from Anthem Blue Cross’ parent company and Transitions Optical, Inc. indicates that the majority o…
Beaver-Visitec International To Focus On Ophthalmic And Microsurgery Products And Services
Beaver-Visitec International (Beaver-Visitec), a new company formed from the purchase of the ophthalmic systems businesses from BD (Becton, Dickinson and Company) and Medtronic, announced today that it will focus solely on products and services for oph…
California: Many Americans In The Dark When Protecting Their Eyes From The Sun
When it comes to working and playing in the great outdoors, many Americans know they should keep their skin protected from the sun; however, a new survey from Anthem Blue Cross’ parent company and Transitions Optical, Inc. indicates that the majority o…